Next Article in Journal
Safety, Tolerability, and Immunogenicity of Interferons
Next Article in Special Issue
Health Economics of Antibiotics
Previous Article in Journal
The Impact of CYP2D6 Genotyping on Tamoxifen Treatment
Previous Article in Special Issue
Lessons Learned from Surveillance of Antimicrobial Susceptibilities of Pseudomonas aeruginosa at a Large Academic Medical Center
Open AccessReview

Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications

Departamento de Microbiologia Geral, Instituto de Microbiologia Prof. Paulo de Góes, CCS, Bloco I, UFRJ, 21941-590, Rio de Janeiro, RJ, Brazil
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2010, 3(4), 1139-1161; https://doi.org/10.3390/ph3041139
Received: 24 March 2010 / Revised: 8 April 2010 / Accepted: 14 April 2010 / Published: 19 April 2010
(This article belongs to the Special Issue Antibiotics)
Lysostaphin is an antimicrobial agent belonging to a major class of antimicrobial peptides and proteins known as the bacteriocins. Bacteriocins are bacterial antimicrobial peptides which generally exhibit bactericidal activity against other bacteria. Bacteriocin production is a self-protection mechanism that helps the microorganisms to survive in their natural habitats. Bacteriocins are currently distributed into three main classes. Staphylococcins are bacteriocins produced by staphylococci, which are Gram-positive bacteria of medical and veterinary importance. Lysostaphin is the only class III staphylococcin described so far. It exhibits a high degree of antistaphylococcal bacteriolytic activity, being inactive against bacteria of all other genera. Infections caused by staphylococci continue to be a problem worldwide not only in healthcare environments but also in the community, requiring effective measures for controlling their spread. Since lysostaphin kills human and animal staphylococcal pathogens, it has potential biotechnological applications in the treatment of staphylococcal infections. In vitro and in vivo studies performed with lysostaphin have shown that this staphylococcin has potential to be used, solely or in combination with other antibacterial agents, to prevent or treat bacterial staphylococcal infectious diseases. View Full-Text
Keywords: lysostaphin; staphylococci; antimicrobial peptides; bacteriocins; staphylococcins lysostaphin; staphylococci; antimicrobial peptides; bacteriocins; staphylococcins
Show Figures

Graphical abstract

MDPI and ACS Style

Bastos, M.C.F.; Coutinho, B.G.; Coelho, M.L.V. Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications. Pharmaceuticals 2010, 3, 1139-1161.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop